Medical Research News

RSS

Researchers map perception of complex blends of odorants

Fragrances - promising mystery, intrigue, and forbidden thrills - are blended by master perfumers, their recipes kept secret.

20 Nov 2020

Authors demonstrate process of misdiagnosis to improve the understanding of congenital heart defect

In a new publication from Cardiovascular Innovations and Applications, Lei Zhang, Tiewei Lv, Xiaoyan Liu, Chuan Feng, Min Zheng, Jie Tian and Huichao Sun from the Children's Hospital of Chongqing Medical University, Chongqing, China and the Chongqing Key Laboratory of Pediatrics, Chongqing, China consider a case of pediatric heart failure caused by the anomalous origin of the left coronary artery from the pulmonary artery.

20 Nov 2020

Researchers solve the mystery of silent hypoxia caused by COVID-19

More than six months since COVID-19 began spreading in the United States, scientists are still solving the many puzzling aspects of how the novel coronavirus attacks the lungs and other parts of the body.

19 Nov 2020

Study investigates link between myocarditis and COVID-19

As the COVID-19 pandemic evolves, so too does research into its effects on heart health. One particular area of interest for physicians involves whether COVID-19 leads to inflammation of the heart muscle, a condition known as myocarditis.

19 Nov 2020

Researchers discover new functions of key cellular machine in cancer

Utah scientists have discovered new functions of a key cellular machine that regulates gene packaging and is mutated in 20% of human cancers.

19 Nov 2020

Researchers compare risk of target organ damage in masked versus sustained hypertension

In a new publication from Cardiovascular Innovations and Applications, Yue Wu, Guoyue Zhang, Rong Hu and Jianlin Du from The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China consider the risk of target organ damage in patients with masked hypertension versus sustained hypertension.

19 Nov 2020

Sinovac Biotech's COVID-19 vaccine candidate triggers immune response

Now, Sinovac Biotech's candidate vaccine, CoronaVac, has been found to induce an immune response in healthy adults aged 18–59 years, 28 days post-vaccination. However, the level of antibodies generated was lower than in people who had recovered from the illness.

19 Nov 2020

College students have lower rates of food insecurity than non-students

College students are significantly less likely to be food insecure than non-students in the same age group, according to a new study from the University of Illinois.

19 Nov 2020

Eating Ataulfo mangoes may reduce facial wrinkles in older women

Mangoes, like other orange fruits and vegetables, are rich in beta-carotene and provide antioxidants that may delay cell damage.

19 Nov 2020

Texas Heart Institute to participate in a study to treat ARDS in hospitalized COVID-19 patients

Texas Heart Institute has been selected as one of up to 60 sites in the world to participate in an international investigative study seeking to aid COVID-19 patients who develop acute respiratory distress syndrome (ARDS).

19 Nov 2020

Hyperbaric oxygen treatments in healthy adults can reverse the aging process, finds study

A new study from Tel Aviv University and the Shamir Medical Center in Israel indicates that hyperbaric oxygen treatments (HBOT) in healthy aging adults can stop the aging of blood cells and reverse the aging process.

19 Nov 2020

Antibody combinations may be more effective at preventing, treating COVID-19

Pairs of antibodies may be more effective than single antibodies at preventing and treating COVID-19, according to a new study by researchers at the University of North Carolina at Chapel Hill and The Rockefeller University in New York.

19 Nov 2020

Survey: Majority of patients favor eliminating processed meats in hospitals

A majority of hospitalized patients favor eliminating processed meats--including bacon, deli meat, and sausage--from hospital menus to reduce cancer risk, according to a new survey published in the Journal of Hospital Management and Health Policy.

19 Nov 2020

High cost of drugs could lead to more than 1.1 million deaths among Medicare recipients

More than 1.1 million Medicare patients could die over the next decade because they cannot afford to pay for their prescription medications, according to a new study released today by the West Health Policy Center, a nonprofit and nonpartisan policy research group and Xcenda, the research arm of the drug distributor AmerisourceBergen.

19 Nov 2020

Afro-Caribbean patients with end stage kidney disease more likely to be hospitalized with COVID-19

Afro-Caribbean people with end stage kidney disease (ESKD) are more likely to be hospitalized with COVID-19 than other ethnicities, a study has found.

19 Nov 2020

Mosaic RBD nanoparticles elicit neutralizing antibodies against SARS-CoV-2

The researchers show that the mice immunized with homotypic or mosaic nanoparticles produced broad binding and neutralizing responses, in contrast to plasma antibodies elicited in humans by SARS-CoV-2 infection. The RBD nanoparticles induced cross-reactive IgG responses in the immunized mice.

19 Nov 2020

Texas Biomed awarded $1 million to evaluate MAb therapeutics for COVID-19

Texas Biomedical Research Institute in San Antonio, Texas, was awarded $1 million from the Bill & Melinda Gates Foundation to test the efficacy of human monoclonal antibodies (MAbs) for the treatment of SARS-CoV-2 infection.

19 Nov 2020

New druggable target for heart failure in neonates and infants identified

Researchers have identified a new druggable target for heart failure in neonates and infants, a condition for which there has been no specific treatment.

19 Nov 2020

Swiss data shows COVID-19 three times more deadly than the flu

Despite this, COVID-19 is often downplayed to be only a seasonal flu by many. This may be because both influenza and COVID-19 have a similar initial presentation, and it is tough to distinguish between the two based on just the clinical presentation.

19 Nov 2020

Cannabis use disorder may increase risk of COVID-19 hospitalization

Researchers in the United States have conducted a study suggesting that genetic vulnerability to a psychiatric syndrome called cannabis use disorder (CUD) may increase the risk of developing severe coronavirus disease 2019 (COVID-19) that requires hospitalization.

19 Nov 2020